| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
67.67(B) |
| Last
Volume: |
918,580 |
Avg
Vol: |
1,403,311 |
| 52
Week Range: |
$230.48 - $283.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 224 |
| Guru Rank Value : 5.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
282 |
3,677 |
9,258 |
39,261 |
| Total Sell Value |
$67,198 |
$869,357 |
$2,420,786 |
$10,261,828 |
| Total People Sold |
1 |
3 |
5 |
7 |
| Total Sell Transactions |
1 |
3 |
7 |
14 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Forlenza Vincent A |
Chairman of the Board |
• • – |
2020-06-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,192 |
198,146 |
|
- |
|
| Kaltenbach Patrick |
EVP & Pres Life Sciences |
• – – |
2020-06-05 |
4 |
AS |
$243.20 |
$255,117 |
D/D |
(1,049) |
11,612 |
|
-2% |
|
| Kaltenbach Patrick |
EVP & Pres Life Sciences |
• – – |
2020-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,027) |
12,661 |
|
- |
|
| Kaltenbach Patrick |
EVP & Pres Life Sciences |
• – – |
2020-06-02 |
4 |
AS |
$244.83 |
$54,352 |
D/D |
(222) |
14,688 |
|
-3% |
|
| Kaltenbach Patrick |
EVP & Pres Life Sciences |
• – – |
2020-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(400) |
14,910 |
|
- |
|
| Forlenza Vincent A |
Chairman of the Board |
• • – |
2020-05-13 |
4 |
GA |
$0.00 |
$0 |
D/D |
10,474 |
219,338 |
|
- |
|
| Fraser-Liggett Claire |
Director |
– • – |
2020-05-08 |
4 |
S |
$256.56 |
$197,808 |
D/D |
(771) |
20,168 |
|
9% |
|
| Banerjee Ranjeet |
President, US Region & CanadaO |
• – – |
2020-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
241 |
|
17% |
|
| Banerjee Ranjeet |
President, US Region & CanadaO |
• – – |
2020-03-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,251 |
|
17% |
|
| Khichi Samrat S. |
EVP and General Counsel |
• – – |
2020-03-16 |
4 |
AS |
$224.53 |
$976,481 |
D/D |
(4,349) |
5,262 |
|
22% |
|
| Khichi Samrat S. |
EVP and General Counsel |
• – – |
2020-02-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
195 |
9,611 |
|
- |
|
| Fraser-Liggett Claire |
Director |
– • – |
2020-02-11 |
4 |
S |
$258.70 |
$388,074 |
D/D |
(1,500) |
20,939 |
|
8% |
|
| Khichi Samrat S. |
EVP and General Counsel |
• – – |
2020-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,338) |
9,806 |
|
- |
|
| Campion Simon D |
EVP and Segment President |
• – – |
2020-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,130) |
9,643 |
|
- |
|
| Larson Betty D |
EVP HR & CHRO |
• – – |
2020-02-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(968) |
7,337 |
|
- |
|
| Campion Simon D |
EVP and Segment President |
• – – |
2020-02-04 |
4 |
AS |
$285.09 |
$2,304,953 |
D/D |
(8,085) |
10,773 |
|
-18% |
|
| Campion Simon D |
EVP and Segment President |
• – – |
2020-02-04 |
4 |
D |
$285.09 |
$1,575,692 |
D/D |
(5,527) |
12,212 |
|
- |
|
| Campion Simon D |
EVP and Segment President |
• – – |
2020-02-04 |
4 |
OE |
$63.66 |
$1,574,621 |
D/D |
13,612 |
13,664 |
|
- |
|
| Mas Ribo Alberto |
EVP and Pres, Life Sciences |
• – – |
2020-02-04 |
4 |
S |
$285.00 |
$407,550 |
D/D |
(1,430) |
8,381 |
|
18% |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2020-01-28 |
4 |
AS |
$280.96 |
$8,011,293 |
D/D |
(28,514) |
208,864 |
|
-12% |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2020-01-28 |
4 |
D |
$280.96 |
$2,766,894 |
D/D |
(9,848) |
237,378 |
|
- |
|
| Forlenza Vincent A |
Chairman, CEO and President |
• • – |
2020-01-28 |
4 |
OE |
$72.12 |
$2,766,667 |
D/D |
38,362 |
247,226 |
|
- |
|
| Scott Bertram L |
Director |
– • – |
2020-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
765 |
29,357 |
|
- |
|
| Eckert R Andrew |
Director |
– • – |
2020-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
765 |
4,555 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2020-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
765 |
76,078 |
|
- |
|
1851 Records found
|
|
Page 11 of 75 |
|
|
1.89 (0.82%) 
